Assessment of Compliance With Antihypertensive Telmisartan Therapy (COAST)

Bayer

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan (Kinzal/Pritor, BAY68-9291)

Study type: Observational

Funder types: Industry

Identifiers

NCT00470886

12827

14237 - KL0710SK (Other Identifier)

KL0710PL (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.

Enrollment: 3,400 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age over 18
• Untreated or ineffectively treated arterial hypertension

Exclusion criteria

• Cholestatic disorders and severe hepatic failure
• Allergy to Telmisartan
• Pregnancy and lactation period
• Unwillingness to participate in the study
• Inability to use the drug reminder device
• Unwillingness to use the drug reminder device

Trial design

3,400 participants in 1 patient group

Group 1

Treatment:

Drug: Telmisartan (Kinzal/Pritor, BAY68-9291)